» Authors » Elizabeth A Wellberg

Elizabeth A Wellberg

Explore the profile of Elizabeth A Wellberg including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 463
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Libby A, Solt C, Jackman M, Sherk V, Foright R, Johnson G, et al.
Am J Physiol Endocrinol Metab . 2024 Mar; 326(5):E626-E639. PMID: 38536037
Loss of ovarian function imparts increased susceptibility to obesity and metabolic disease. These effects are largely attributed to decreased estradiol (E), but the role of increased follicle-stimulating hormone (FSH) in...
2.
Sankofi B, Valencia-Rincon E, Sekhri M, Ponton-Almodovar A, Bernard J, Wellberg E
Front Endocrinol (Lausanne) . 2023 Oct; 14:1217875. PMID: 37800138
Obesity and type 2 diabetes are chronic metabolic diseases that impact tens to hundreds of millions of adults, especially in developed countries. Each condition is associated with an elevated risk...
3.
Thomas N, Scalzo R, Wellberg E
Nat Rev Endocrinol . 2023 Oct; 20(1):16-26. PMID: 37783846
Breast cancer is the most common invasive malignancy in the world, with millions of survivors living today. Type 2 diabetes mellitus (T2DM) is also a globally prevalent disease that is...
4.
Diedrich J, Gonzalez-Pons R, Medeiros H, Ensink E, Liby K, Wellberg E, et al.
Biochem Pharmacol . 2023 Aug; 216:115763. PMID: 37625554
Anti-hormone therapies are not efficacious for reducing the incidence of triple negative breast cancer (TNBC), which lacks both estrogen and progesterone receptors. While the etiology of this aggressive breast cancer...
5.
Castillo-Castrejon M, Sankofi B, Murguia S, Udeme A, Cen H, Xia Y, et al.
Breast Cancer Res . 2023 Aug; 25(1):99. PMID: 37608351
Background: Obesity increases breast cancer risk and breast cancer-specific mortality, particularly for people with estrogen receptor (ER)-positive tumors. Body mass index (BMI) is used to define obesity, but it may...
6.
Leo J, Dondossola E, Basham K, Wilson N, Alhalabi O, Gao J, et al.
Endocrinology . 2023 May; 164(6). PMID: 37154098
The androgen receptor (AR) is one of the oldest therapeutic targets in oncology and continues to dominate the treatment landscape for advanced prostate cancer, where nearly all treatment regimens include...
7.
Geitgey D, Lee M, Cottrill K, Jaffe M, Pilcher W, Bhasin S, et al.
J Natl Cancer Inst Monogr . 2023 May; 2023(61):12-29. PMID: 37139973
The obesity pandemic currently affects more than 70 million Americans and more than 650 million individuals worldwide. In addition to increasing susceptibility to pathogenic infections (eg, SARS-CoV-2), obesity promotes the...
8.
Sanchez L, Epps J, Wall S, McQueen C, Pearson S, Scribner K, et al.
Cell Death Differ . 2023 Mar; 30(6):1472-1487. PMID: 36966227
The functionally differentiated mammary gland adapts to extreme levels of stress from increased demand for energy by activating specific protective mechanisms to support neonatal health. Here, we identify the breast...
9.
Wellberg E, Corleto K, Checkley L, Jindal S, Johnson G, Higgins J, et al.
Breast Cancer Res . 2022 Jun; 24(1):42. PMID: 35725493
Background: Obesity and adult weight gain are linked to increased breast cancer risk and poorer clinical outcomes in postmenopausal women, particularly for hormone-dependent tumors. Menopause is a time when significant...
10.
MacCuaig W, Thomas A, Claros-Sorto J, Gomez-Gutierrez J, Alexander A, Wellberg E, et al.
Biotech Histochem . 2022 Jan; 97(1):1-10. PMID: 34979848
There are racial disparities in the outcome of triple negative breast cancer (TNBC) patients between women of African ancestry and women of European ancestry, even after accounting for lifestyle, socioeconomic...